116 related articles for article (PubMed ID: 12349956)
1. Inhibitory effects of relaxin on human basophils activated by stimulation of the Fc epsilon receptor. The role of nitric oxide.
Bani D; Baronti R; Vannacci A; Bigazzi M; Sacchi TB; Mannaioni PF; Masini E
Int Immunopharmacol; 2002 Jul; 2(8):1195-204. PubMed ID: 12349956
[TBL] [Abstract][Full Text] [Related]
2. Role of nitric oxide in histamine release from human basophils and rat peritoneal mast cells.
Peh KH; Moulson A; Wan BY; Assem EK; Pearce FL
Eur J Pharmacol; 2001 Aug; 425(3):229-38. PubMed ID: 11513842
[TBL] [Abstract][Full Text] [Related]
3. Carbon monoxide modulates the response of human basophils to FcepsilonRI stimulation through the heme oxygenase pathway.
Vannacci A; Baronti R; Zagli G; Marzocca C; Pierpaoli S; Bani D; Passani MB; Mannaioni PF; Masini E
Eur J Pharmacol; 2003 Apr; 465(3):289-97. PubMed ID: 12681441
[TBL] [Abstract][Full Text] [Related]
4. Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells.
Failli P; Nistri S; Quattrone S; Mazzetti L; Bigazzi M; Sacchi TB; Bani D
FASEB J; 2002 Feb; 16(2):252-4. PubMed ID: 11744624
[TBL] [Abstract][Full Text] [Related]
5. Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation.
Gibbs BF; Räthling A; Zillikens D; Huber M; Haas H
J Allergy Clin Immunol; 2006 Nov; 118(5):1060-7. PubMed ID: 17088130
[TBL] [Abstract][Full Text] [Related]
6. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells.
Bani D; Masini E; Bello MG; Bigazzi M; Sacchi TB
Cancer Res; 1995 Nov; 55(22):5272-5. PubMed ID: 7585587
[TBL] [Abstract][Full Text] [Related]
7. Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture.
Bani D; Failli P; Bello MG; Thiemermann C; Bani Sacchi T; Bigazzi M; Masini E
Hypertension; 1998 Jun; 31(6):1240-7. PubMed ID: 9622136
[TBL] [Abstract][Full Text] [Related]
8. Relaxin-induced increased coronary flow through stimulation of nitric oxide production.
Bani-Sacchi T; Bigazzi M; Bani D; Mannaioni PF; Masini E
Br J Pharmacol; 1995 Sep; 116(1):1589-94. PubMed ID: 8564223
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway.
Masini E; Zagli G; Ndisang JF; Solazzo M; Mannaioni PF; Bani D
Br J Pharmacol; 2002 Oct; 137(3):337-44. PubMed ID: 12237253
[TBL] [Abstract][Full Text] [Related]
10. CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation.
Sabato V; Verweij MM; Bridts CH; Levi-Schaffer F; Gibbs BF; De Clerck LS; Schiavino D; Ebo DG
Cytometry B Clin Cytom; 2012 May; 82(3):132-8. PubMed ID: 22173928
[TBL] [Abstract][Full Text] [Related]
11. Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide.
Masini E; Bani D; Bello MG; Bigazzi M; Mannaioni PF; Sacchi TB
Endocrinology; 1997 Nov; 138(11):4713-20. PubMed ID: 9348198
[TBL] [Abstract][Full Text] [Related]
12. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.
Genovese A; Patella V; De Crescenzo G; De Paulis A; Spadaro G; Marone G
Clin Exp Allergy; 1997 May; 27(5):559-67. PubMed ID: 9179431
[TBL] [Abstract][Full Text] [Related]
13. Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils.
Ebo DG; Bridts CH; Mertens CH; Hagendorens MM; Stevens WJ; De Clerck LS
J Immunol Methods; 2012 Jan; 375(1-2):30-8. PubMed ID: 21945198
[TBL] [Abstract][Full Text] [Related]
14. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.
Sabroe RA; Francis DM; Barr RM; Black AK; Greaves MW
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):651-8. PubMed ID: 9802375
[TBL] [Abstract][Full Text] [Related]
15. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
16. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.
Niimi N; Francis DM; Kermani F; O'Donnell BF; Hide M; Kobza-Black A; Winkelmann RK; Greaves MW; Barr RM
J Invest Dermatol; 1996 May; 106(5):1001-6. PubMed ID: 8618029
[TBL] [Abstract][Full Text] [Related]
17. IgE regulates mouse basophil Fc epsilon RI expression in vivo.
Lantz CS; Yamaguchi M; Oettgen HC; Katona IM; Miyajima I; Kinet JP; Galli SJ
J Immunol; 1997 Mar; 158(6):2517-21. PubMed ID: 9058781
[TBL] [Abstract][Full Text] [Related]
18. Relaxin and nitric oxide signalling.
Baccari MC; Bani D
Curr Protein Pept Sci; 2008 Dec; 9(6):638-45. PubMed ID: 19075752
[TBL] [Abstract][Full Text] [Related]
19. Endogenous superallergen protein Fv induces IL-4 secretion from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE.
Patella V; Giuliano A; Bouvet JP; Marone G
J Immunol; 1998 Nov; 161(10):5647-55. PubMed ID: 9820545
[TBL] [Abstract][Full Text] [Related]
20. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.
Zhu D; Kepley CL; Zhang M; Zhang K; Saxon A
Nat Med; 2002 May; 8(5):518-21. PubMed ID: 11984598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
